Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;80(1):18-27.
doi: 10.1159/000351943. Epub 2013 Jul 13.

Dominant form of congenital hyperinsulinism maps to HK1 region on 10q

Affiliations

Dominant form of congenital hyperinsulinism maps to HK1 region on 10q

Sara E Pinney et al. Horm Res Paediatr. 2013.

Abstract

Background/aims: In a family with congenital hyperinsulinism (HI), first described in the 1950s by McQuarrie, we examined the genetic locus and clinical phenotype of a novel form of dominant HI.

Methods: We surveyed 25 affected individuals, 7 of whom participated in tests of insulin dysregulation (24-hour fasting, oral glucose and protein tolerance tests). To identify the disease locus and potential disease-associated mutations we performed linkage analysis, whole transcriptome sequencing, whole genome sequencing, gene capture, and next generation sequencing.

Results: Most affecteds were diagnosed with HI before age one and 40% presented with a seizure. All affecteds responded well to diazoxide. Affecteds failed to adequately suppress insulin secretion following oral glucose tolerance test or prolonged fasting; none had protein-sensitive hypoglycemia. Linkage analysis mapped the HI locus to Chr10q21-22, a region containing 48 genes. Three novel noncoding variants were found in hexokinase 1 (HK1) and one missense variant in the coding region of DNA2.

Conclusion: Dominant, diazoxide-responsive HI in this family maps to a novel locus on Chr10q21-22. HK1 is the more attractive disease gene candidate since a mutation interfering with the normal suppression of HK1 expression in beta-cells could readily explain the hypoglycemia phenotype of this pedigree.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pedigree of family with autosomal dominant congenital hyperinsulinism. Generation is indicated by number and family members are denoted with a letter. Males depicted as squares, females as circles, deceased individuals by a slashed line. Filled symbols are individuals diagnosed with hypoglycemia (n=25); hatched symbols are obligate carriers (n=5). Diamonds indicate number of unaffected descendants. Dashed lines outline original pedigree reported by McQuarrie (1). Asterisks indicate family members described in Table 1.
Figure 2
Figure 2
(a) Linkage analysis showing LOD score of 6.82 at chromosome 10q21–22. Shaded bar indicates the 11.1 cM shared haplotype region spanning 8.2 Mb and containing 48 genes. (b) Location of 3 novel disease-associated variants in non-coding regions of HK1. The promoters of the three HK1 isoforms are identified: PT (testes specific), PE (erythrocyte specific), and PU (ubiquitous). Tissue specific exons are designated T1-T6 and E1. Exons 2–18 are shared by all 3 isoforms. Transcription start sites are indicated with arrows.
Figure 2
Figure 2
(a) Linkage analysis showing LOD score of 6.82 at chromosome 10q21–22. Shaded bar indicates the 11.1 cM shared haplotype region spanning 8.2 Mb and containing 48 genes. (b) Location of 3 novel disease-associated variants in non-coding regions of HK1. The promoters of the three HK1 isoforms are identified: PT (testes specific), PE (erythrocyte specific), and PU (ubiquitous). Tissue specific exons are designated T1-T6 and E1. Exons 2–18 are shared by all 3 isoforms. Transcription start sites are indicated with arrows.

Similar articles

Cited by

References

    1. Stanley CA, De Leon DD, editors. Monogenic hyperinsulinemic hypoglycemia disorders. Basal, Switzerland: Karger; 2012. p. 21.
    1. McQuarrie I. Idiopathic spontaneously occurring hypoglycemia in infants: Clinical significance of problem and treatment. American Journal of Diseases of Childhood. 1954;87:399. - PubMed
    1. De Leon DD, Stanley CA. Mechanisms of disease: Advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab. 2007;3:57–68. - PubMed
    1. Monogenic disorders of insulin secretion: Congenital hyperinsulinism and neonatal diabetes. Pediatric Diabetes. 2012;13:344–368.
    1. Finegold DN, Stanley CA, Baker L. Glycemic response to glucagon during fasting hypoglycemia: An aid in the diagnosis of hyperinsulinism. J Pediatr. 1980;96:257–259. - PubMed

Publication types

MeSH terms